Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Oral Iron in Pediatric CKD with IDA
NCT01155375Phase 3Terminated
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Oct 2011
- Primary completion
- Jun 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Oct 2011; status: terminated.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01155375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155375.